home / stock / gth / gth news


GTH News and Press, Genetron Holdings Limited From 03/17/21

Stock Information

Company Name: Genetron Holdings Limited
Stock Symbol: GTH
Market: NASDAQ
Website: genetronhealth.com

Menu

GTH GTH Quote GTH Short GTH News GTH Articles GTH Message Board
Get GTH Alerts

News, Short Squeeze, Breakout and More Instantly...

GTH - Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021

Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, ...

GTH - Genetron Health to Present at Science/AAAS Webinar About Early Cancer Screening on March 31

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today ann...

GTH - Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, t...

GTH - Genetron Health's Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today an...

GTH - Genetron Health to Release Thirteen Research Findings at 21st World Conference on Lung Cancer

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today an...

GTH - Genetron Health to Present at BTIG Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day on Jan. 22, 2021

Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, ...

GTH - Genetron Health, Sino Biopharm's subsidiary inks strategic partnership for HCCscreen in China

Genetron Holdings (GTH) and Chia Tai Tianqing Pharmaceutical Group, a subsidiary of Sino Biopharmaceutical (SBHMY) and a leading liver drug franchise with a major presence in liver disease hospitals in China entered in an exclusive strategic partnership agreement for HCCscreen,...

GTH - Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen(TM) in China

Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharm, has a leading liver drug franchise with a major presence in liver disease hospitals in China Genetron Health anticipates that commercialization and revenue growth of HCCscreen ™ will acc...

GTH - U.S. IPO Weekly Recap: Airbnb And DoorDash Make Their Public Debuts In A 10 IPO Week

Four IPOs and one SPAC are scheduled to raise $1.7 billion in the week ahead. Street research is expected for six companies. Lock-up periods will be expiring for eight companies. For further details see: U.S. IPO Weekly Recap: Airbnb And DoorDash Make Their Public Debuts...

GTH - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs

Genetron Health, a Beijing-North Caroline diagnostic company, announced a city-wide early screening test for liver cancer in Wuxi city using the company's blood-based HCCscreen. Sinopharm has filed for China approval of at least one of its two COVID-19 inactivated vaccines based on in...

Previous 10 Next 10